DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tenuate Dospan is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
A generic version of TENUATE DOSPAN was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Nostrum Labs Inc||TENUATE DOSPAN||diethylpropion hydrochloride||TABLET, EXTENDED RELEASE;ORAL||012546-001||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|